Dr. Lisheng Wang
Dr. Lisheng Wang

PhD, University of Sydney (1999)

Roger Guindon Hall, Room 4104 (office), 4105 (lab)
613-562-5624 (Office)
613-562-5800 ext. 8208 (Lab)


Biographical Sketch

Dr. Lisheng Wang is a Professor in the Department of Biochemistry, Microbiology, and Immunology at University of Ottawa, a Core Member at the Ottawa Institute of Systems Biology, and an Affiliated Investigator at the Ottawa Health Research Institute. He graduated from Medical School in China and received his clinical training as a Fellow in Australian National Liver Transplantation Unit. Dr. Wang completed a PhD at the University of Sydney (Australia) studying the transplantation immunology. He then pursued postdoctoral research in immunology at Harvard Medical School, USA, and further postdoctoral research in stem cell biology and regenerative medicine at Robarts Research Institute, Canada.

Research Interests

Using cellular and molecular approaches and in vivo animal models, Dr. Wang’s laboratory is interested in:

  1. Nurturing human embryonic stem cells (hESCs) into mothers of circulatory cells and immune cells for stem cell-based clinic therapy and reducing transplantation rejection;
  2. Targeting embryonic signaling pathways in breast cancer for more effective treatment.

For further information, please contact Dr. Lisheng Wang at 613-562-5624 or [email protected]

Selected Publications (from 80 articles)​​​​​​

  • Zikuan Gu, Yueru Dong, Shuxin Xu, Lisheng Wang and Zhen Liu. Molecularly imprinted polymer-based smart prodrug delivery system for specific targeting, prolonged retention and tumor microenvironment-triggered release (Original Report). Angewandte Chemie-International Edition 2021;60:2663-2667. https://doi.org/10.1002/anie.202012956
  • Sara El-Sahli, Khang Hua, Andrew Sulaiman, Jason Chambersa, Li Li, Elijah Farah, Dan Liu, Sarah McGarry, Peiyong Zheng, Seung-Hwan Lee, Jiefeng Cui, Marc Ekker, Marceline Cote, Tommy Alain, Xuguang Li, Vanessa D’Costa, Lisheng Wang@ and Suresh Gadde@ (@corresponding author). A triple-drug nanotherapy to target breast cancer cells, cancer stem cells and tumor vasculature (Original Report). Cell Death & Disease 2020; 12: 8. https://doi.org/10.1038/s41419-020-03308-w
  • Shuxin Xu, Lisheng Wang and Zhen Liu. Molecularly Imprinted Polymer Nanoparticles: An Emerging Versatile Platform for Cancer Nanomedicine (Review). Angewandte Chemie- International Edition 2020. https://onlinelibrary.wiley.com/doi/10.1002/anie.202005309

Research interests

  • Embryonic stem cells
  • Regenerative medicine
  • Immune cells
  • Cancer stem cells
  • Microbiology
  • Biochemistry